AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Quinoline Derivatives as Anti-Cancer Agents

Summary: Methods of preparing quinoline derivative compounds, and administering such compounds in the treatment of solid and non-solid tumors, notably on liver cancer.

Countries: European

Supplementary Information: Inventor: CHAN, Albert Sun-chi | TANG, Johnny Cheuk-on | LAM, Kim-hung | CHUI, Chung-hin | KOK, Stanton Hon-lung | CHAN, Sau Hing | CHEUNG, Filly | FERRARA, Roberto Gambari | CHENG, Chor Hing
Priority Number: EP2188259B1
IPC Current: C07D021526 | A61K0031438 | A61P003500
Assignee Applicant: The Hong Kong Polytechnic University
Title: QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | CHINOLINDERIVATE ALS ANTIKREBSMITTEL | DÉRIVÉS DE QUINOLÉINE EN TANT QU'AGENTS ANTICANCÉREUX
Usefulness: QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | CHINOLINDERIVATE ALS ANTIKREBSMITTEL | DÉRIVÉS DE QUINOLÉINE EN TANT QU'AGENTS ANTICANCÉREUX
Summary: For treating cancer e.g. solid or non-solid tumor, breast carcinoma, hepatocellulor carcinoma or chronic myelogenous leukemia in mammal (claimed).
Novelty: Use of quinoline derivative compound for treating cancer e.g. solid or non-solid tumor, breast carcinoma, hepatocellular carcinoma and chronic myelogenous leukemia

Industry: Disease Diagnostic/Treatment

Sub Category: Cancer/Tumor

Others: CHAN Sun-chi Albert
TANG Cheuk-on Johnny
LAM Kim-hung
CHUI Chung-hin
KOK Hon-lung Stanton
CHEUNG Filly
CHAN Sau-hing
CHENG Chor-hing

For more information, please click Here